Evidence map›Paper›PMID 31123897›Full record

ArticlePurinergic signalling2019

The ectonucleoside triphosphate diphosphohydrolase-2 (NTPDase2) in human endometrium: a novel marker of basal stroma and mesenchymal stem cells.

Carla Trapero, August Vidal, Aitor Rodríguez-Martínez, Jean Sévigny, Jordi Ponce, Buenaventura Coroleu, Xavier Matias-Guiu, Mireia Martín-Satué

Abstract read
In one paragraph

Article in Purinergic signalling, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
3.4field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 18 citations in OpenAlex.

  1. Article
  2. Review
  3. Review
  4. Review
  5. Review
  6. Article
  7. Review
  8. Review
  9. Purinergic Signaling in Endometriosis-Associated Pain.International journal of molecular sciences · 2020
    Review
  10. Article
  11. Article
  12. Review
  13. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 4 institutions in 2 countries.

Carla TraperoDepartament de Patologia i Terapèutica Experimental, Facultat de Medicina i Ciències de la Salut, Campus Bellvitge, Universitat de Barcelona, Barcelona, Spain.
August VidalDepartament de Patologia i Terapèutica Experimental, Facultat de Medicina i Ciències de la Salut, Campus Bellvitge, Universitat de Barcelona, Barcelona, Spain.
Aitor Rodríguez-MartínezDepartament de Patologia i Terapèutica Experimental, Facultat de Medicina i Ciències de la Salut, Campus Bellvitge, Universitat de Barcelona, Barcelona, Spain.
Jean SévignyCentre de Recherche du CHU de Québec, Université Laval, Québec City, QC, Canada.
Jordi PonceInstitut d'Investigació Biomèdica de Bellvitge (IDIBELL), Oncobell Program, CIBERONC, Barcelona, Spain.
Buenaventura CoroleuHospital Universitari Quiron Dexeus, Salud de la Mujer Dexeus, Barcelona, Spain.
Xavier Matias-GuiuInstitut d'Investigació Biomèdica de Bellvitge (IDIBELL), Oncobell Program, CIBERONC, Barcelona, Spain.
Mireia Martín-SatuéDepartament de Patologia i Terapèutica Experimental, Facultat de Medicina i Ciències de la Salut, Campus Bellvitge, Universitat de Barcelona, Barcelona, Spain. martinsatue@ub.edu.ORCID 0000-0002-9718-4664
Bellvitge University Hospital · ESInstitut d'Investigació Biomédica de Bellvitge · ESHospital Universitario Dexeus · ESUniversité Laval · CA

Funding

CIHR
6 · The paper itself

Abstract

The human endometrium undergoes repetitive regeneration cycles in order to recover the functional layer, shed during menses. The basal layer, which remains in charge of endometrial regeneration in every cycle, contains adult stem or progenitor cells of epithelial and mesenchymal lineage. Some pathologies such as adenomyosis, in which endometrial tissue develops within the myometrium, originate from this layer. It is well known that the balance between adenosine triphosphate (ATP) and adenosine plays a crucial role in stem/progenitor cell physiology, influencing proliferation, differentiation, and migration. The extracellular levels of nucleotides and nucleosides are regulated by the ectonucleotidases, such as the nucleoside triphosphate diphosphohydrolase 2 (NTPDase2). NTPDase2 is a membrane-expressed enzyme found in cells of mesenchymal origin such as perivascular cells of different tissues and the stem cells of adult neurogenic regions. The aim of this study was to characterize the expression of NTPDase2 in human nonpathological cyclic and postmenopausic endometria and in adenomyosis. We examined proliferative, secretory, and atrophic endometria from women without endometrial pathology and also adenomyotic lesions. Importantly, we identified NTPDase2 as the first marker of basal endometrium since other stromal cell markers such as CD10 label the entire stroma. As expected, NTPDase2 was also found in adenomyotic stroma, thus becoming a convenient tracer of these lesions. We did not record any changes in the expression levels or the localization of NTPDase2 along the cycle, thus suggesting that the enzyme is not influenced by the female sex hormones like other previously studied ectoenzymes. Remarkably, NTPDase2 was expressed by the Sushi Domain containing 2 (SUSD2)

Indexed as

AdenomyosisAdenosine TriphosphatasesAdultAgedAged, 80 and overBiomarkersEndometriumFemaleHumansMesenchymal Stem CellsMiddle AgedStromal CellsAdenosine TriphosphatasesBiomarkersectoATPaseAdenomyosisEctonucleotidasesMSCPurinergic signalingSUSD2

Identifiers

PMID31123897
PMCPMC6657408
OpenAlexW2945167597

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.